Anthocyanin supplementation improves serum LDL- and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects

被引:309
作者
Qin, Yu [1 ]
Xia, Min [1 ]
Ma, Jing [1 ]
Hao, YuanTao [2 ]
Liu, Jing [1 ]
Mou, HaiYing [1 ]
Cao, Li [1 ]
Ling, WenHua [1 ]
机构
[1] Sun Yat Sen Univ, Dept Nutr, Sch Publ Hlth, Northern Campus,74 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Dept Stat, Guangzhou 510080, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
ATHEROSCLEROTIC PLAQUE-FORMATION; LOW-DENSITY-LIPOPROTEIN; CARDIOVASCULAR-DISEASE; EFFLUX; FRUIT; RISK; LIVER; MACROPHAGES; CONSUMPTION; VEGETABLES;
D O I
10.3945/ajcn.2009.27814
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Anthocyanins have been shown to exert benefits on the lipid profile in many animal models. Whether these molecules have similar beneficial effects in humans is currently unknown. Objective: The objective was to investigate the effects of berry-derived anthocyanin supplements on the serum lipid profile in dyslipidemic patients. Design: A total of 120 dyslipidemic subjects (age 40-65 y) were given 160 mg anthocyanins twice daily or placebo for 12 wk in a double-blind, randomized, placebo-controlled trial. Results: Anthocyanin consumption increased HDL-cholesterol concentrations (13.7% and 2.8% in the anthocyanin and placebo groups, respectively; P < 0.001) and decreased LDL-cholesterol concentrations (13.6% and -0.6% in the anthocyanin and placebo groups, respectively; P < 0.001). Cellular cholesterol efflux to serum increased more in the anthocyanin group than in the placebo group (20.0% and 0.2%, respectively; P < 0.001). Anthocyanin supplementation decreased the mass and activity of plasma cholesteryl ester transfer protein (CETP) (10.4% and 6.3%, respectively, in the anthocyanin group and -3.5% and 1.1%, respectively, in the placebo group; P < 0.001). In the anthocyanin group, the change in HDL cholesterol was negatively correlated with the change in CETP activity (r(s) = -0.330). The change in LDL cholesterol was positively correlated with the change in CETP mass (r(s) = 0.354). The change in cellular cholesterol efflux to serum was positively correlated with the change in HDL cholesterol (r(s) = 0.485). In vitro, cyanidin 3-O-beta-glucosides dose-dependently lowered CETP activity in human HepG2 cells. Conclusions: Anthocyanin supplementation in humans improves LDL- and HDL-cholesterol concentrations and enhances cellular cholesterol efflux to serum. These benefits may be due to the inhibition of CETP. Am J Clin Nutr 2009;90:485-92.
引用
收藏
页码:485 / 492
页数:8
相关论文
共 33 条
[1]   HDL cholesterol and protective factors in atherosclerosis [J].
Assmann, G ;
Gotto, AM .
CIRCULATION, 2004, 109 (23) :8-14
[2]   RELATION OF HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL AND TRIGLYCERIDES TO INCIDENCE OF ATHEROSCLEROTIC CORONARY-ARTERY DISEASE (THE PROCAM EXPERIENCE) [J].
ASSMANN, G ;
SCHULTE, H .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (07) :733-737
[3]   Moderate alcohol consumption increases cholesterol efflux mediated by ABCA1 [J].
Beulens, JWJ ;
Sierksma, A ;
van Tol, A ;
Fournier, N ;
van Gent, T ;
Paul, JL ;
Hendriks, HFJ .
JOURNAL OF LIPID RESEARCH, 2004, 45 (09) :1716-1723
[4]  
BISGAIER CL, 1993, J LIPID RES, V34, P1625
[5]   Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol [J].
Brousseau, ME ;
Schaefer, EJ ;
Wolfe, ML ;
Bloedon, LT ;
Digenio, AG ;
Clark, RW ;
Mancuso, JP ;
Rader, DJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1505-1515
[6]   Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: a meta-analysis of 23 randomized lipid trials [J].
Brown, B. Greg ;
Stukovsky, Karen Hinckley ;
Zhao, Xue-Qiao .
CURRENT OPINION IN LIPIDOLOGY, 2006, 17 (06) :631-636
[7]   Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol [J].
Erlund, Iris ;
Koli, Raika ;
Alfthan, Georg ;
Marniemi, Jukka ;
Puukka, Pauli ;
Mustonen, Pirjo ;
Mattila, Pirjo ;
Jula, Antti .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2008, 87 (02) :323-331
[8]  
FIELDING CJ, 1995, J LIPID RES, V36, P211
[9]   Enhanced efflux of cholesterol from ABCA1-expressing macrophages to serum from type IV hypertriglyceridemic subjects [J].
Fournier, N ;
Francone, O ;
Rothblat, G ;
Goudouneche, D ;
Cambillau, M ;
Kellner-Weibel, G ;
Robinet, P ;
Royer, L ;
Moatti, N ;
Simon, A ;
Paul, JL .
ATHEROSCLEROSIS, 2003, 171 (02) :287-293
[10]   Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report [J].
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, R ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Cleeman, JI ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ ;
Keller, SA ;
Jehle, AJ .
CIRCULATION, 2002, 106 (25) :3143-3421